Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hagedoorn

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Expert Opinion on Drug Delivery|November 7, 2014
The role of disposable inhalers in pulmonary drug deliveryAnne H de Boer, Paul Hagedoorn
Expert Opinion on Drug Delivery|August 19, 2022
Dry powder inhalation, part 1: ancient history and precursors to modern dry powder inhalersAnne Haaije de Boer, Paul Hagedoorn, Floris Grasmeijer
Expert Opinion on Drug Delivery|August 19, 2022
Dry powder inhalation, part 2: the present and futureAnne Haaije de Boer, Paul Hagedoorn, Floris Grasmeijer
Pharmaceutics|May 16, 2019
Characterization and Formulation of Isoniazid for High-Dose Dry Powder InhalationImco Sibum, Paul Hagedoorn, Henderik W Frijlink, et al.
The Journal of Pharmacy and Pharmacology|August 14, 2012
Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhalerAnne H de Boer, Paul Hagedoorn, Robert Woolhouse, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 30, 2015
Can 'extrafine' dry powder aerosols improve lung deposition?Anne H de Boer, Doetie Gjaltema, Paul Hagedoorn, et al.
Plos One|July 12, 2013
Mixing time effects on the dispersion performance of adhesive mixtures for inhalationFloris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, et al.
International Journal of Pharmaceutics|September 4, 2012
Characterisation of high dose aerosols from dry powder inhalersFloris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, et al.
Plos One|August 23, 2013
Drug content effects on the dispersion performance of adhesive mixtures for inhalationFloris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, et al.
Respiratory Medicine|June 16, 2014
The clinical relevance of dry powder inhaler performance for drug deliveryPascal Demoly, Paul Hagedoorn, Anne H de Boer, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Delivery|November 7, 2014
The role of disposable inhalers in pulmonary drug deliveryAnne H de Boer, Paul Hagedoorn
Expert Opinion on Drug Delivery|August 19, 2022
Dry powder inhalation, part 1: ancient history and precursors to modern dry powder inhalersAnne Haaije de Boer, Paul Hagedoorn, Floris Grasmeijer
Expert Opinion on Drug Delivery|August 19, 2022
Dry powder inhalation, part 2: the present and futureAnne Haaije de Boer, Paul Hagedoorn, Floris Grasmeijer
Pharmaceutics|May 16, 2019
Characterization and Formulation of Isoniazid for High-Dose Dry Powder InhalationImco Sibum, Paul Hagedoorn, Henderik W Frijlink, et al.
The Journal of Pharmacy and Pharmacology|August 14, 2012
Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhalerAnne H de Boer, Paul Hagedoorn, Robert Woolhouse, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 30, 2015
Can 'extrafine' dry powder aerosols improve lung deposition?Anne H de Boer, Doetie Gjaltema, Paul Hagedoorn, et al.
Plos One|July 12, 2013
Mixing time effects on the dispersion performance of adhesive mixtures for inhalationFloris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, et al.
International Journal of Pharmaceutics|September 4, 2012
Characterisation of high dose aerosols from dry powder inhalersFloris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, et al.
Plos One|August 23, 2013
Drug content effects on the dispersion performance of adhesive mixtures for inhalationFloris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, et al.
Respiratory Medicine|June 16, 2014
The clinical relevance of dry powder inhaler performance for drug deliveryPascal Demoly, Paul Hagedoorn, Anne H de Boer, et al.
Pageof 5